Amantadine Clinical Trial
The study was a single center observational-prospective study and approved by local ethics committee. Patients in coma state due to traumatic brain injury, cardiac arrest or ischemic stroke who are older than 18 years of age were included in the study. Patients who received amantadine 200mg/day for fourteen days according to ICU protocols decided by primary physician formed the amantadine group, and the rest of the subjects were included in the control group. All patients were evaluated for Glasgow Coma Score, JFK Coma Recovery Scale and Disability Rating Scale once a week for three months.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT06443827 -
Effect of Intravenous Amantadine Sulphate on Disorders of Consciousness
|
Phase 2 | |
| Recruiting |
NCT04367883 -
Influenza Vaccination, ACEI and ARB in the Evolution of SARS-CoV2 Infection
|